US Patent Issued to Noema Pharma on Feb. 10 for "Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome" (Swiss Inventor)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,364, issued on Feb. 10, was assigned to Noema Pharma AG (Basel, Switzerland).

"Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome" was invented by George Garibaldi (Basel, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of treating Tourette Syndrome in a subject in need thereof by administering to the subject compositions comprising a PDE10 inhibitor. Also disclosed are crystalline solid forms of the compound of Formula I and uses thereof:"

The patent was filed on Dec. 5, 2023, under Application No. 18/529,506.

*For further information, including images, charts and tables, please v...